Clinical Trials Browser

Phase 2 × Carcinoma, Signet Ring Cell × Leucovorin × Clear all

NCT05504252 2026-01-07

METIMMOX-2

Phase 2 Active not recruiting

Adenocarcinoma, Mucinous, Carcinoma, Signet Ring Cell